What GIANT Biosystems is building
GIANT BioSystems develops a rapid antimicrobial susceptibility testing (AST) platform that delivers actionable results in hours to enable faster, targeted therapy decisions. Its technology helps clinicians reduce treatment delays and improve outcomes in severe infections.
Pitch Pulse context
GIANT Biosystems is part of Pitch Pulse's published Bio finalist cohort.
